Table 2 Association between LGR5 and β-catenin protein expression in breast cancer by stratifying molecular subtype
From: LGR5 overexpression confers poor relapse-free survival in breast cancer patients
β-catenin IHC | ||||
|---|---|---|---|---|
N | Low (%) | High (%) | p-value | |
All patients, LGR5 IHC | ||||
Low | 62 | 33 (53) | 29 (47) | 0.948 |
High | 57 | 30 (53) | 27 (47) | |
Non-TNBC, LGR5 IHC | ||||
Low | 57 | 29 (51) | 28 (49) | 0.252 |
High | 45 | 28 (62) | 17 (38) | |
TNBC, LGR5 IHC | ||||
Low | 5 | 4 (80) | 1 (20) | 0.013 |
High | 12 | 2 (17) | 10 (83) | |